
Dr. Carolyn Myers
President & CEO
Dr. Carolyn Myers
Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading healthcare businesses. Dr. Myers is currently CEO of FendX Technologies Inc. and a Principal of Bioensemble LLC where she works closely with numerous start-ups and small pharma companies to assist them in developing their business strategy and planning. Her previous executive positions include Vice President International Business Development and Alliance Management at Allergan PLC, President of Dey Laboratories and President of Mylan Technologies Inc. Prior to serving in these roles, Dr. Myers served in various management positions in sales and marketing at Pharmacia Corporation., now a part of Pfizer, Inc. Dr. Myers earned her PhD in genetics from the University of British Columbia and her MBA from Rutgers University.
Dr. Myers is a member of the board of directors of publicly held Mayne Pharma and Hyloris Pharmaceuticals, a Steering Committee Member of Mid Atlantic Bio Angels, a Healthcare Committee Member of Golden Seeds Angels, and a Member of the Licensing Executive’s Society.